Through in vitro scratch assays and transwell migration and invasion assays, we further confirmed that Linc00485 silencing significantly reduced the migrative and invasive capabilities of lung cancer cells (A549, H460, and H1975) (Figure 3A‐F), whereas the overexpression of Linc00485 significantly enhanced malignant phenotypes of A549 cells (Figure 3G,H). Here, LINC00485 is linked to lung carcinoma.